David S Silberstein, PhD

Harvard Medical School (1984-1994) leading NIH-funded research on biochemistry of inflammation; AstraZeneca/MedImmune (1994-2013), leading pharmacology and chemistry initiatives, supporting science lead for products with aggregate sales >$30B; >50 peer-reviewed publications; 22 patents
COO
email: david.silberstein@bmxpharma.com